HALOHalozymeHealth Care
$66.54EarningsAug 4, 2026
1D—1W—1M—3M—1Y—
Market cap$8.2BCompany infoRevenue$1.5B52-wk range$52 – $82IndustryBiotechnologyWebsitehalozyme.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +23.5% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E23.9×5054
12
39
P / S5.4×2530
5
16
P / FCF12.2×7383
12
45
EV / EBITDA10.4×7382
10
29
P / E (fwd)8.2×——
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin76.9%8981
76%
83%
Operating margin57.0%9899
35%
64%
Net margin23.1%8487
23%
92%
ROE109.9%9898
92%
219%
ROIC25.2%9093
13%
30%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity9.7610
3.0
43.9
Net debt / EBITDA1.9×4340
Current ratio2.768166
Interest coverage45.0×8679
Per shareTTM, with year-over-year change
Revenue / share$12.28▲ +39%
EPS (diluted)$2.78▼ −26%
FCF / share$5.43▲ +35%
Est. EPS growth (fwd)+22%